The long-term goals of this project are to understand the function and regulation of protein phosphorylation in control of cell growth, proliferation and differentiation, and the molecular mechanism of growth factor-induced signal transduction. Cell growth is the integrated outcome of cellular response to the extracellular environment, including nutrients, growth factors, and stress conditions. Cell mass accumulation is mainly reflected by the rate of protein synthesis. Tuberous sclerosis (TSC) is an autosomal dominant genetic disorder occurring in 1/6000 of the population. TSC is characterized by the development of harmatomas in a wide range of human tissues. Mutations in either the TSCI or TSC2 tumor suppressor gene are responsible for TSC. Recent genetic studies indicate that the TSC genes are involved in cell growth regulation. However, the precise molecular functions of TSC1 and TSC2 gene products in cell growth regulation are unknown. The major goals of this proposal are to test the model that TSC1/TSC2 play a central role of receiving both extracellular and intracellular signals to regulate cell growth. TSC1/TSC2 functions in vivo to regulation protein translation by inhibiting the phosphorylation and activity of the p70 ribosomal S6 kinase. Biochemical and cell biological approaches will be used to investigate the regulation of TSC2 by phosphorylation in response to growth factor stimulation, nutrient and ATP depletion, and cellular stress conditions.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM051586-12
Application #
7031772
Study Section
Special Emphasis Panel (ZRG1-CDF-1 (01))
Program Officer
Anderson, Richard A
Project Start
1994-08-01
Project End
2007-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
12
Fiscal Year
2006
Total Cost
$345,653
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Biochemistry
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Liu, Meng-Xi; Jin, Lei; Sun, Si-Jia et al. (2018) Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma. Oncogene 37:1637-1653
Chen, Lei-Lei; Lin, Huai-Peng; Zhou, Wen-Jie et al. (2018) SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. Cell Rep 25:1485-1500.e4
Han, Han; Qi, Ruxi; Zhou, Jeff Jiajing et al. (2018) Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein Interaction. Mol Cell 72:328-340.e8
Meng, Zhipeng; Qiu, Yunjiang; Lin, Kimberly C et al. (2018) RAP2 mediates mechanoresponses of the Hippo pathway. Nature 560:655-660
Ma, Shenghong; Guan, Kun-Liang (2018) Polycystic kidney disease: a Hippo connection. Genes Dev 32:737-739
Ye, Dan; Guan, Kun-Liang; Xiong, Yue (2018) Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates. Trends Cancer 4:151-165
Plouffe, Steven W; Lin, Kimberly C; Moore 3rd, Jerrell L et al. (2018) The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell. J Biol Chem 293:11230-11240
Ma, Xi; Zhang, Shen; He, Long et al. (2017) MTORC1-mediated NRBF2 phosphorylation functions as a switch for the class III PtdIns3K and autophagy. Autophagy 13:592-607
Hong, Audrey W; Meng, Zhipeng; Yuan, Hai-Xin et al. (2017) Osmotic stress-induced phosphorylation by NLK at Ser128 activates YAP. EMBO Rep 18:72-86
Lin, Kimberly C; Park, Hyun Woo; Guan, Kun-Liang (2017) Regulation of the Hippo Pathway Transcription Factor TEAD. Trends Biochem Sci 42:862-872

Showing the most recent 10 out of 76 publications